A Cambridge MedTech has been acquired for £4.5 billion following a battle for control in the boardroom. Abcam plc initiated a strategic review in June after founder Jonathan Milner had tried and failed to seize back control of the company, listed on New York’s Nasdaq exchange since 2020, which he founded in 1998. Milner, who … Continue reading Cambridge MedTech sold for £4.5bn after boardroom battle